Industry leaders support repurposing research in various ways. We work with industry leaders in pharma, biotech and device companies of all sizes and the service providers to industry including CROs, CMOs, consulting and other companies that serve them. They collaborate in various ways to develop treatments for patients with unmet medical needs. These patients do not currently have effective therapeutic options available and are not being fully served by currently branded and/or generic products on the market.
We appreciate our relationship with industry leaders. Industry understands and supports CWR’s goal to take proven therapies and funding the Phase I, proof-of-concept trial (where CWR focuses its effort) is an incredibly valuable stage of support. In addition, these randomized controlled trials provide the critical evidence needed for larger, confirmatory studies (Phase II or III).